Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.
Researchers from the University of Pittsburgh have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy.